These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37147642)

  • 1. Treating nightmares in posttraumatic stress disorder with dronabinol: study protocol of a multicenter randomized controlled study (THC PTSD-trial).
    Roepke S; Schoofs N; Priebe K; Wülfing F; Schmahl C; Röhle R; Zähringer J; Lotter T; Otte C; Koglin S
    BMC Psychiatry; 2023 May; 23(1):319. PubMed ID: 37147642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study.
    Jetly R; Heber A; Fraser G; Boisvert D
    Psychoneuroendocrinology; 2015 Jan; 51():585-8. PubMed ID: 25467221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: a randomized controlled trial.
    Krakow B; Hollifield M; Johnston L; Koss M; Schrader R; Warner TD; Tandberg D; Lauriello J; McBride L; Cutchen L; Cheng D; Emmons S; Germain A; Melendrez D; Sandoval D; Prince H
    JAMA; 2001 Aug; 286(5):537-45. PubMed ID: 11476655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder.
    Raskind MA; Thompson C; Petrie EC; Dobie DJ; Rein RJ; Hoff DJ; McFall ME; Peskind ER
    J Clin Psychiatry; 2002 Jul; 63(7):565-8. PubMed ID: 12143911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pilot, Randomized Clinical Trial of Bedtime Doses of Prazosin Versus Placebo in Suicidal Posttraumatic Stress Disorder Patients With Nightmares.
    McCall WV; Pillai A; Case D; McCloud L; Nolla T; Branch F; Youssef NA; Moraczewski J; Tauhidul L; Pandya CD; Rosenquist PB
    J Clin Psychopharmacol; 2018 Dec; 38(6):618-621. PubMed ID: 30335633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxazosin, an α-1-adrenergic-receptor Antagonist, for Nightmares in Patients with Posttraumatic Stress Disorder and/or Borderline Personality Disorder: a Chart Review.
    Roepke S; Danker-Hopfe H; Repantis D; Behnia B; Bernard F; Hansen ML; Otte C
    Pharmacopsychiatry; 2017 Jan; 50(1):26-31. PubMed ID: 27276365
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study.
    Raskind MA; Peskind ER; Kanter ED; Petrie EC; Radant A; Thompson CE; Dobie DJ; Hoff D; Rein RJ; Straits-Tröster K; Thomas RG; McFall MM
    Am J Psychiatry; 2003 Feb; 160(2):371-3. PubMed ID: 12562588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder.
    Taylor F; Raskind MA
    J Clin Psychopharmacol; 2002 Feb; 22(1):82-5. PubMed ID: 11799347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation.
    Cameron C; Watson D; Robinson J
    J Clin Psychopharmacol; 2014 Oct; 34(5):559-64. PubMed ID: 24987795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans.
    Raskind MA; Peskind ER; Chow B; Harris C; Davis-Karim A; Holmes HA; Hart KL; McFall M; Mellman TA; Reist C; Romesser J; Rosenheck R; Shih MC; Stein MB; Swift R; Gleason T; Lu Y; Huang GD
    N Engl J Med; 2018 Feb; 378(6):507-517. PubMed ID: 29414272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prazosin treatment of nightmares related to posttraumatic stress disorder.
    Dierks MR; Jordan JK; Sheehan AH
    Ann Pharmacother; 2007 Jun; 41(6):1013-7. PubMed ID: 17504838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol.
    Maier A; Dharan A; Oliver G; Berk M; Redston S; Back SE; Kalivas P; Ng C; Kanaan RA
    BMC Psychiatry; 2020 Aug; 20(1):397. PubMed ID: 32762663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder.
    Raskind MA; Peskind ER; Hoff DJ; Hart KL; Holmes HA; Warren D; Shofer J; O'Connell J; Taylor F; Gross C; Rohde K; McFall ME
    Biol Psychiatry; 2007 Apr; 61(8):928-34. PubMed ID: 17069768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prazosin for treatment of nightmares related to posttraumatic stress disorder.
    Taylor HR; Freeman MK; Cates ME
    Am J Health Syst Pharm; 2008 Apr; 65(8):716-22. PubMed ID: 18387899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Double-Blind, Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Posttraumatic Stress Disorder and Comorbid Depression.
    Ramaswamy S; Driscoll D; Reist C; Smith LM; Albers LJ; Rose J; Nguyen L; Monga V; Doria R; Hollifield M
    Prim Care Companion CNS Disord; 2017 Aug; 19(4):. PubMed ID: 28858440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD.
    Yeh MS; Mari JJ; Costa MC; Andreoli SB; Bressan RA; Mello MF
    CNS Neurosci Ther; 2011 Oct; 17(5):305-10. PubMed ID: 21554564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
    Brady K; Pearlstein T; Asnis GM; Baker D; Rothbaum B; Sikes CR; Farfel GM
    JAMA; 2000 Apr; 283(14):1837-44. PubMed ID: 10770145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder.
    Mello MF; Yeh MS; Barbosa Neto J; Braga LL; Fiks JP; Mendes DD; Moriyama TS; Valente NL; Costa MC; Mattos P; Bressan RA; Andreoli SB; Mari JJ
    BMC Psychiatry; 2009 May; 9():28. PubMed ID: 19480669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrally acting anticholinergic drug trihexyphenidyl is highly effective in reducing nightmares associated with post-traumatic stress disorder.
    Sogo K; Sogo M; Okawa Y
    Brain Behav; 2021 Jun; 11(6):e02147. PubMed ID: 33991066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trial.
    Talbot LS; Maguen S; Metzler TJ; Schmitz M; McCaslin SE; Richards A; Perlis ML; Posner DA; Weiss B; Ruoff L; Varbel J; Neylan TC
    Sleep; 2014 Feb; 37(2):327-41. PubMed ID: 24497661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.